Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration

Bone

Volumn 50, Issue 4, 2012, Pages 974-982

  Lee, Deok Won ^a   Yun, Young Pil ^b   Park, Kyeongsoon ^c   Kim, Sung Eun ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Antibacterial activity; Bone morphogenic protein 2; Gentamicin; Osteointegration; Titanium

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; DOPAMINE; GENTAMICIN; HEPARIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TITANIUM;

ADHESION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BONE DEVELOPMENT; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; IMPLANT; IN VITRO STUDY; MINERALIZATION; NONHUMAN; OSTEOBLAST; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; X RAY PHOTOELECTRON SPECTROSCOPY;

ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL DEATH; CELL LINE; CELL PROLIFERATION; DOPAMINE; DRUG DELIVERY SYSTEMS; GENTAMICINS; HEPARIN; HUMANS; IMMOBILIZED PROTEINS; IMPLANTS, EXPERIMENTAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; OSSEOINTEGRATION; OSTEOBLASTS; PHOTOELECTRON SPECTROSCOPY; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862794152     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.01.007     Document Type: Article

References (33)

1. Pohler O.E. Unalloyed titanium for implants in bone surgery. Injury 2000, 31(Suppl 4):7-13.
2. Puleo D.A., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20(23-24):2311-2321.
3. Rupp F., Scheideler L., Olshanska N., de Wild M., Wieland M., Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A 2006, 76(2):323-334.
4. Piskounova S., Forsgren J., Brohede U., Engqvist H., Stromme M. In vitro characterization of bioactive titanium dioxide/hydroxyapatite surfaces functionalized with BMP-2. J Biomed Mater Res B Appl Biomater 2009, 91(2):780-787.
5. Shi Z., Neoh K.G., Kang E.T., Poh C.K., Wang W. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules 2009, 10(6):1603-1611.
6. Oya K., Tanaka Y., Saito H., Kurashima K., Nogi K., Tsutsumi H., et al. Calcification by MC3T3-E1 cells on RGD peptide immobilized on titanium through electrodeposited PEG. Biomaterials 2009, 30(7):1281-1286.
7. Balasundaram G., Webster T.J. Increased osteoblast adhesion on nanograined Ti modified with KRSR. J Biomed Mater Res A 2007, 80(3):602-611.
8. Miron R.J., Oates C.J., Molenberg A., Dard M., Hamilton D.W. The effect of enamel matrix proteins on the spreading, proliferation and differentiation of osteoblasts cultured on titanium surfaces. Biomaterials 2010, 31(3):449-460.
9. King G.N., King N., Cruchley A.T., Wozney J.M., Hughes F.J. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997, 76(8):1460-1470.
10. Zellin G., Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res 1997, 35(2):181-190.
11. Kim J., Kim I.S., Cho T.H., Lee K.B., Hwang S.J., Tae G., et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007, 28(10):1830-1837.
12. Shi Z., Neoh K.G., Kang E.T., Poh C., Wang W. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng Part A 2009, 15(2):417-426.
13. Chua P.H., Neoh K.G., Kang E.T., Wang W. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 2008, 29(10):1412-1421.
14. Lee T.C., Ho J.T., Hung K.S., Chen W.F., Chung Y.H., Yang Y.L. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery 2006, 58(2):373-380.
15. Sasisekharan R., Ernst S., Venkataraman G. On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis 1997, 1(1):45-54.
16. Ishibe T., Goto T., Kodama T., Miyazaki T., Kobayashi S., Takahashi T. Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 108(6):867-875.
17. Park J.S., Park K., Woo D.G., Yang H.N., Chung H.M., Park K.H. Triple constructs consisting of nanoparticles and microspheres for bone-marrow-derived stromal-cell-delivery microscaffolds. Small 2008, 4(11):1950-1955.
18. Kim S.E., Song S.H., Yun Y.P., Choi B.J., Kwon I.K., Bae M.S., et al. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32(2):366-373.
19. Campoccia D., Montanaro L., Arciola C.R. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006, 27(11):2331-2339.
20. von Eiff C., Jansen B., Kohnen W., Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 2005, 65(2):179-214.
21. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284(5418):1318-1322.
22. Shi Z., Neoh K.G., Kang E.T., Poh C., Wang W. Bacterial adhesion and osteoblast function on titanium with surface-grafted chitosan and immobilized RGD peptide. J Biomed Mater Res A 2008, 86(4):865-872.
23. Lee H., Scherer N.F., Messersmith P.B. Single-molecule mechanics of mussel adhesion. Proc Natl Acad Sci USA 2006, 103(35):12999-13003.
24. Fan X., Lin L., Dalsin J.L., Messersmith P.B. Biomimetic anchor for surface-initiated polymerization from metal substrates. J Am Chem Soc 2005, 127(45):15843-15847.
25. Lee H., Dellatore S.M., Miller W.M., Messersmith P.B. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007, 318(5849):426-430.
26. Schierholz J.M., Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001, 49(2):87-93.
27. MacKintosh E.E., Patel J.D., Marchant R.E., Anderson J.M. Effects of biomaterial surface chemistry on the adhesion and biofilm formation of Staphylococcus epidermidis in vitro. J Biomed Mater Res A 2006, 78(4):836-842.
28. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237(4822):1588-1595.
29. Turksen K., Bhargava U., Moe H.K., Aubin J.E. Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo. J Histochem Cytochem 1992, 40(9):1339-1352.
30. van den Beucken J.J., Walboomers X.F., Boerman O.C., Vos M.R., Sommerdijk N.A., Hayakawa T., et al. Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2. J Control Release 2006, 113(1):63-72.
31. Bancroft G.N., Sikavitsas V.I., van den Dolder J., Sheffield T.L., Ambrose C.G., Jansen J.A., et al. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 2002, 99(20):12600-12605.
32. Gay C.V., Gilman V.R., Sugiyama T. Perspectives on osteoblast and osteoclast function. Poult Sci 2000 Jul, 79(7):1005-1008.
33. Missiaen L., Wuytack F., Raeymaekers L., De Smedt H., Droogmans G., Declerck I., et al. Ca2+ extrusion across plasma membrane and Ca2+ uptake by intracellular stores. Pharmacol Ther 1991, 50(2):191-232.